CVS, Caremark sweeten offer to $26.3B

CVS Corp. (NYSE: CVS) and Caremark Rx Inc. (NYSE: CMX) today announced “enhancements” to their planned merger in response to rival Express Scripts’ (Nasdaq: ESRX) sweetening last night of its $26.1 billion hostile takeover offer. In what CVS called its “best and final merger proposal,” it and Caremark agreed to increase their special cash dividend…

Want More?

Register or subscribe with
Providence Business News to continue reading.

Register Now

Subscribe for $1

Already registered? Login to access more articles.

*Registered users get access to a limited number of free articles every month.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -